Tetrabutylammonium Fluoride → HCID 178508371, 화합물
반응식
[F:1][C:2]([F:43])([F:42])[C:3]1[CH:4]=[C:5]([C:13]2[O:41][C:16]3=[C:17]([NH2:40])[N:18]=[CH:19][C:20]([C:21]4[CH:22]=[N:23][N:24]([CH:26]5[CH2:31][CH2:30][CH:29]([O:32][Si](C(C)(C)C)(C)C)[CH2:28][CH2:27]5)[CH:25]=4)=[C:15]3[CH:14]=2)[CH:6]=[C:7]([C:9]([F:12])([F:11])[F:10])[CH:8]=1.[F-].C([N+](CCCC)(CCCC)CCCC)CCC>C1COCC1.CCOC(C)=O>[NH2:40][C:17]1[N:18]=[CH:19][C:20]([C:21]2[CH:22]=[N:23][N:24]([C@H:26]3[CH2:31][CH2:30][C@H:29]([OH:32])[CH2:28][CH2:27]3)[CH:25]=2)=[C:15]2[CH:14]=[C:13]([C:5]3[CH:6]=[C:7]([C:9]([F:10])([F:11])[F:12])[CH:8]=[C:3]([C:2]([F:43])([F:1])[F:42])[CH:4]=3)[O:41][C:16]=12참가 물질
5
실험 절차
A solution of 2-[3,5-bis(trifluoromethyl)phenyl]-4-[1-(4-{[tert-butyl(dimethyl)silyl]oxy}cyclohexyl)-1H-pyrazol-4-yl]furo[2,3-c]pyridin-7-amine (104 mg) in THF (2 mL) was treated with tetra-n-butylammonium fluoride (2.7 M in water, 0.20 mL, 0.56 mmol) and stirred at RT overnight. The solution was diluted with EtOAc and washed with brine. The aqueous phase was extracted with EtOAc and the combined organic fractions were dried over sodium sulfate and concentrated. Purification of the residue by ISCO chromatography (0 to 5% 7 N NH3/MeOH:EtOAc) afforded 33 mg (35%) of the title compound as a yellow solid. 1H NMR (400 MHz, CD3OD): δ 1.48-1.60 (m, 2H) 2.01 (qd, J=12.7, 3.2 Hz, 2H) 2.10-2.26 (m, 4H) 3.73 (tt, J=10.9, 4.1 Hz, 1H) 4.26 (tt, J=11.9, 3.9 Hz, 1H) 7.88 (s, 1H) 7.91-7.94 (m, 2H) 8.00-8.03 (m, 1H) 8.12-8.15 (m, 1H) 8.67 (s, 2H); MS (ESI): 510.34 [M+H]+; HPLC tR=1.16 min (TOF: polar—3 min).